[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100467980":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":39,"centralContacts":46,"locations":54,"responsibleParty":71,"collaborators":73,"id":77,"slug":78,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":30,"eligibilityCriteria":83,"healthyVolunteers":79,"sex":84,"minAge":85,"maxAge":30,"enrollmentInfo":86,"targetDuration":30,"studyType":89,"phases":90,"briefSummary":92,"conditions":93,"keywords":95,"overallStatus":56,"whyStopped":30,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Rutgers, The State University of New Jersey","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Enhance MSS using multi-level stakeholder collaboration (Mo.1-15)","EXPERIMENTAL","Enhancements of MSS to increase intervention effects - theory - based strategies (PHM), (BCT)",[13],"Other: MySmartSkin enhancement",{"label":15,"type":10,"description":16,"interventionNames":17},"Involves the longitudinal RCT comparing behavioral outcomes and effectiveness (Mo.16 -60)","RCT of enhanced MSS testing effectiveness (thorough SSE, sun protection behavior Involves the longitudinal RCT comparing behavioral outcomes and effectiveness of enhanced MSS versus an educational webpage on SSE as well as new recurrences\u002Fmelanomas",[18],"Other: Educational webpage on Skin Self-Examination",{"label":20,"type":21,"description":22,"interventionNames":23},"Aim 3: Assess implementation outcomes, identify factors relevant for future scale-up (Mo.17-60)","ACTIVE_COMPARATOR","Assessment of implementation outcomes and key contextual factors from the perspective of multi - level stakeholders",[24],"Other: Assess implementation outcomes",[26,31,35],{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"MySmartSkin enhancement","Focuses on MySmartSkin web application\u002Fintervention including enhancements using stakeholder collaboration and input",[9],null,{"type":6,"name":32,"description":33,"armGroupLabels":34,"otherNames":30},"Educational webpage on Skin Self-Examination","Longitudinal RCT comparing behavioral outcomes and effectiveness of enhanced MSS versus an educational webpage on SSE as well as new recurrences\u002Fmelanomas",[15],{"type":6,"name":36,"description":37,"armGroupLabels":38,"otherNames":30},"Assess implementation outcomes","A mixed-methods study with multi-level stakeholders to assess implementation outcomes and identify contextual factors to facilitate scale-up for future dissemination and implementation.",[20],[40,44],{"name":41,"affiliation":42,"role":43},"Sharon Manne, PhD","Rutgers Cancer Institute of New Jersey","PRINCIPAL_INVESTIGATOR",{"name":45,"affiliation":42,"role":43},"Carolyn Heckman, PhD",[47,51],{"name":41,"role":48,"phone":49,"phoneExt":30,"email":50},"CONTACT","732-235-6759","mannesl@cinj.rutgers.edu",{"name":45,"role":48,"phone":52,"phoneExt":30,"email":53},"732-266-9514","ch842@cinj.rutgers.edu",[55],{"facility":42,"status":56,"city":57,"state":58,"zip":59,"country":60,"countryCode":61,"cosmosGeoPoint":62,"geoPoint":67,"contacts":68},"RECRUITING","New Brunswick","New Jersey","08901","United States","US",{"type":63,"coordinates":64},"Point",[65,66],-74.45182,40.48622,{"lat":66,"lon":65},[69],{"name":41,"role":48,"phone":49,"phoneExt":30,"email":70},"Sharon.Manne@rutgers.edu",{"type":43,"investigatorFullName":41,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"Associate Director for Cancer Prevention, Control and Population Science",[74],{"name":75,"class":76},"National Cancer Institute (NCI)","NIH","100467980","mysmartskin-online-skin-self-exam-intervention-for-melanoma-survivors-100467980",false,"NCT05373823","MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors","A Digital Intervention to Improve Skin Self-examination Among Melanoma Survivors","Inclusion Criteria:\n\n* Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma\n* Three months to five years post-surgery\n* No current evidence of cancer\n* Not adherent to thorough SSE (i.e., did not check entire body at least once during the past three months)\n* ≥ 18 years old\n* Internet access\n* Able to speak\u002Fread English\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Children","ALL","18 Years",{"count":87,"type":88},385,"ESTIMATED","INTERVENTIONAL",[91],"NA","This project, mySmartSkin (MSS), includes an innovative Type 1 hybrid effectiveness-implementation trial designed to enhance the effects of MSS and simultaneously assess key implementation outcomes (e.g., cost, adoption) as well as contextual factors important for scale-up in community and health care settings where melanoma survivors receive follow-up care. A type 1 hybrid effectiveness-implementation design allows us to engage multilevel stakeholders throughout this process, evaluate the effectiveness of the enhanced MSS, and identify critical factors for wide-scale implementation. Aim 1 will focus on enhancing the previous version of MSS by collaborating with multi-level stakeholders in qualitative interviews and usability testing. Aim 2 will evaluate the effects of enhanced MSS on thorough skin-self examinations (SSE) in a randomized-control trial (RCT) and examine its impact on the diagnosis of new\u002Frecurrent melanomas. Aim 3 will focus on assessing selected implementation outcomes and identify factors relevant to future scale-up for widespread dissemination and implementation.",[94],"Melanoma",[96],"Self-Examination","2026-07-27",{"date":99,"type":100},"2026-07-28","ACTUAL",{"date":102,"type":100},"2023-03-06",{"date":104,"type":88},"2027-03-31",{"name":5,"class":6},1]